United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time gene therapy for the treatment of patients with vision loss due to a ...

United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Equities research analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of United Therapeutics in a ...

HIGH POINT, N.C., March 20, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin, a potential ...

WASHINGTON — A federal judge on Thursday temporarily blocked billionaire Elon Musk’s Department of Government Efficiency from Social Security systems that hold personal data on millions of Americans, ...

On one hand, the Trump administration is closing Social Security offices. On the other, it’s sending beneficiaries to those same offices. By Steve Benen Donald Trump has spent years presenting ...

HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 Upon FDA approval, commercial launch activities to commence immediately ...